Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 184, Issue 1, Pages 118-125
Publisher
Wiley
Online
2015-12-13
DOI
10.1111/cei.12754
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Soluble C5b-9 as a Biomarker for Complement Activation in Atypical Hemolytic Uremic Syndrome
- (2015) Fengxiao Bu et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Current Understanding of the Role of Complement in IgA Nephropathy
- (2015) N. Maillard et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Eculizumab in the Treatment of Membranoproliferative Glomerulonephritis
- (2015) Andrew S. Bomback NEPHRON CLINICAL PRACTICE
- Defining the Complement Biomarker Profile of C3 Glomerulopathy
- (2014) Y. Zhang et al. Clinical Journal of the American Society of Nephrology
- Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome
- (2014) Mihály Józsi et al. IMMUNOLOGY LETTERS
- A Novel Antibody against Human Properdin Inhibits the Alternative Complement System and Specifically Detects Properdin from Blood Samples
- (2014) Diana Pauly et al. PLoS One
- Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage
- (2014) Seiji Nagamachi et al. BMC Nephrology
- Alternative Complement Pathway Activation Products in Urine and Kidneys of Patients with ANCA-Associated GN
- (2013) S.-J. Gou et al. Clinical Journal of the American Society of Nephrology
- C3 glomerulopathy: consensus report
- (2013) Matthew C. Pickering et al. KIDNEY INTERNATIONAL
- Recent insights into C3 glomerulopathy
- (2013) Thomas D. Barbour et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin
- (2013) M. Alcorlo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Local release of properdin in the cellular microenvironment: role in pattern recognition and amplification of the alternative pathway of complement
- (2013) Claudio Cortes et al. Frontiers in Immunology
- Properdin and Factor H: Opposing Players on the Alternative Complement Pathway “See-Saw”
- (2013) Lubna Kouser et al. Frontiers in Immunology
- Factor H and Properdin Recognize Different Epitopes on Renal Tubular Epithelial Heparan Sulfate
- (2012) Azadeh Zaferani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combination of Factor H Mutation and Properdin Deficiency Causes Severe C3 Glomerulonephritis
- (2012) A. M. Lesher et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation
- (2012) Danielle Paixão-Cavalcante et al. KIDNEY INTERNATIONAL
- Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement
- (2010) Viviana P. Ferreira et al. IMMUNOBIOLOGY
- Urinary properdin excretion is associated with intrarenal complement activation and poor renal function
- (2009) M. A. Siezenga et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Properdin and Complement Activation: A Fresh Perspective
- (2008) Dennis Hourcade CURRENT DRUG TARGETS
- Properdin: New roles in pattern recognition and target clearance
- (2008) Claudia Kemper et al. MOLECULAR IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now